
Pharmacokinetics of Moxifloxacin in an Infant With Mycoplasma hominis Meningitis
Author(s) -
Kevin M. Watt,
Matthew M. Massaro,
Brian P. Smith,
Michael CohenWolkowiez,
Daniel K. Benjamin,
Matthew M. Laughon
Publication year - 2012
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0b013e31823980c3
Subject(s) - moxifloxacin , mycoplasma hominis , pharmacokinetics , medicine , doxycycline , meningitis , antibiotics , pneumonia , mycoplasma , pediatrics , microbiology and biotechnology , biology
Treatment of Mycoplasma hominis meningitis in infants is limited by a lack of consensus regarding therapy and limited pharmacokinetic data for agents to which M. hominis is susceptible. We report the successful treatment of a premature infant suffering from M. hominis meningitis with doxycycline and moxifloxacin and provide a pharmacokinetic profile of moxifloxacin.